Exciting news! 🇪🇺 Novartis has received a positive CHMP opinion for Remibrutinib in Chronic Spontaneous Urticaria (CSU).
We are proud to have collaborated with the Novartis team on the autoantibody analysis presented at #AAAAI2026 (Abstract #022). www.jacionline.org/article/S009...
#autoantibodies
@drrobinreschke.bsky.social I am incredibly excited to have performed the autoantibody analysis 🧪✨ for this groundbreaking work. jitc.bmj.com/content/14/1...
Anti-MASR autoantibodies found in Parkinson’s Disease. A new study reveals a PD-specific RAS autoantibody network-adding MASR to the growing list of GPCR targets.
🔗 doi.org/10.3390/anti...
Still fond of peptide science—especially how bioactive peptides shape disease. A recent review dives into Chromogranin A: a single precursor yielding peptides that can drive or resolve inflammation. Cleavage is key. Fascinating stuff! #proteomics #immunology
www.frontiersin.org/journals/imm...
Eben wusste ich noch, was ich antworten wollte
Excited to be presenting today at the Labroots Immuno-Oncology Virtual Event Series 2025!
I'll be sharing our approach to profiling autoantibodies in immuno-oncology and autoimmune diseases - focused on both response prediction and safety profiling.
www.labroots.com/virtual-even...
Potent autoantibodies to IFN-γ & GM-CSF are emerging as key drivers of invasive fungal infections - especially in Southeast Asians with HLA-DRB1*15:02. Fungal mimicry may trigger them. Wild stuff.
#autoimmunity #autoantibodies
doi.org/10.1084/jem....
Are you interested in learning about my company @oncimmune ? We perform multiplexed #autoantibody profiling in patients with autoimmune diseases, cancer or during infections. Ower partner @Luminex has featured in their recent spotlight video. youtu.be/llW67W0isL4?fe… via @YouTube
How are liquid biopsies changing cancer treatment? By delivering information on the cancer using a simple blood draw in cases where traditional biopsies are not possible. Learn more in the latest issue of Cancer Today magazine: www.cancertodaymag.org/spring-2025/...
A recent study published in Frontiers in Immunology sheds light on how anti-cardiac myosin AAbs cross-react with β-adrenergic receptors (βAR), contributing to fibrosis, reduced recovery, and worse prognosis in myocarditis patients. Front. Immunol. 16:1500909. doi: 10.3389/fimmu.2025.1500909
HAPPY INTERNATIONAL WOMENS DAY!
Thrilled that our co-authored paper on autoantibody profiling in myositis has been featured by @acr-journals.bsky.social #autoantibodies
I’m happy to have contributed to this study, which sheds light on how certain autoantibodies drive inflammation in lupus and idiopathic inflammatory myopathies (IIMs) through TLR7/8 activation. acrjournals.onlinelibrary.wiley.com/share/NHGDFV...
www.linkedin.com/posts/activi...
festive, scientific illustration with Dortmund city visible through the window.
Anyone else racing to finalise a manuscript or tackle reviewer comments before the Christmas holidays? 🎄✍️ Wishing everyone a productive and peaceful end to the year!
#Autoantibodies
In 2014, we identified BICD2 #autoantibodies in systemic sclerosis (SSc) patients. Nearly a decade later, independent studies have validated its high specificity for SSc and its association with altered lung function. Biomarker discoveries take years to undergo rigorous diagnostic validation.
Traditionally, IgE antibodies are known for their role in allergic responses, but exciting new research is highlighting the growing importance of IgE autoantibodies in several autoimmune diseases and beyond. Interested? Here is my blog www.linkedin.com/pulse/what-m... #autoantibodies #IgE